Dr. Premkumar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Holy Name Medical Center
718 Teaneck Rd
Teaneck, NJ 07666Phone+1 201-227-8008- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2017 - 2020
- Tulane UniversityResidency, Internal Medicine, 2014 - 2017
- Duke University HospitalPost-Doctoral Fellowship, Department of Medicine, Division of Pulmonary and Critical Care, Transfusion Medicine, 2013 - 2014
- Tulane University School of MedicineClass of 2013, M.D.
- Tulane University School of Medicine, Hayward Genetics CenterM.S., Biological Sciences; Concentration: Human Genetics, 2008 - 2009
- Cornell UniversityB.A., Mathematics, 2004 - 2008
Certifications & Licensure
- NY State Medical License 2017 - 2026
- NJ State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- American Society of Hematology Abstract Achievement Award American Society of Hematology, 2013
- Arnold P. Gold Foundation Help for Haiti Student Fellowship Grant Arnold P. Gold Foundation, 2010
- Abstract Achievement Award American Society of Hematology, 2013
Publications & Presentations
PubMed
- 40 citationsVenetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis, , , , , , , , , , , , , , , , > ;Blood Cancer Journal. 2021 Jan 11
- 5 citationsModern Treatments and Future Directions for Relapsed/Refractory Multiple Myeloma Patients.Vikram Premkumar, Suzanne Lentzsch> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Nov 1
- 9 citationsUse of daratumumab in high risk multiple myeloma: A meta-analysis.Vikram Premkumar, Samuel Pan, Suzanne Lentzsch, Bhutani, D.> ;Ejhaem. 2020 Jul 1
- Join now to see all
Journal Articles
- Venetoclax in AL Amyloidosis- is this the beginning or the end?Premkumar, V., Comenzo, R., Lentzsch, S, Clinical Lymphoma, Myeloma and Leukemia, 2019
- Antagonists of the System L Neutral Amino Acid Transporter (LAT) Promote Endothelial Adhesivity of Human Red Blood CellsDosier, L, Premkumar, V, Zhu, H, et al., Thrombosis and Haemostasis, 2017
- A Rare Presentation and Challenging Reconstruction of an Extensive Cystic Orbital SchwannomaHo, S., Premkumar, V, Valenzuela, A, Palacios, E, Vision Pan-America- The Pan-American Journal of Ophthalmology, 2013
- Join now to see all
Abstracts/Posters
- Sequencing of Treatments in Metastatic CRPC for Patients Who Have Completed All Therapeutic Interventions.Steinberger, A., Ledet, E., Feibus, A., Premkumar, V., Dotiwala, A., Stolten, M., Lewis, B., Sartor, AO., Genitourinary Cancers Symposium, San Francisco, CA, 1/1/2016
- Listen to Your Brain But Follow Your Heart.Premkumar, V., Davies, L., Hospital Medicine- Society of Hospital Medicine Annual Meeting; Society of General Internal Medicine Southern Regional Meeting, Atlanta, GA, 2016; San Diego, CA, 2016, 1/1/2016
Hospital Affiliations
- New York-Presbyterian HospitalNew York, New York
- Holy Name Medical CenterTeaneck, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: